Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leroux is a historic French company founded in 1858 that has evolved from a traditional chicory producer into a leader in food science and prebiotic research. The company specializes in the extraction and application of chicory-derived compounds, particularly inulin, which is widely recognized for its benefits to the gut microbiome and digestive health. Leroux operates a dedicated research and development center that collaborates with academic institutions to study the physiological effects of chicory fiber on metabolic health and satiety. Their product portfolio includes both consumer-facing chicory beverages and industrial ingredients used in the nutraceutical and functional food sectors. By bridging the gap between traditional agriculture and modern life sciences, Leroux remains a key player in the global prebiotic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leroux.